Cibus Global LLC

NASDAQ:CBUS USA Biotechnology
Market Cap
$243.03 Million
Market Cap Rank
#16806 Global
#6437 in USA
Share Price
$3.68
Change (1 day)
+3.37%
52-Week Range
$1.16 - $4.05
All Time High
$1574.00
About

Cibus, Inc., an agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products. It focuses on trait productivity in the productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable i… Read more

Cibus Global LLC (CBUS) - Total Liabilities

Latest total liabilities as of September 2025: $278.20 Million USD

Based on the latest financial reports, Cibus Global LLC (CBUS) has total liabilities worth $278.20 Million USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Cibus Global LLC - Total Liabilities Trend (2015–2024)

This chart illustrates how Cibus Global LLC's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Cibus Global LLC Competitors by Total Liabilities

The table below lists competitors of Cibus Global LLC ranked by their total liabilities.

Liability Composition Analysis (2015–2024)

This chart breaks down Cibus Global LLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.28 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 5.52 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.84 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cibus Global LLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cibus Global LLC (2015–2024)

The table below shows the annual total liabilities of Cibus Global LLC from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 $252.24 Million +22.38%
2023-12-31 $206.12 Million +1257.10%
2022-12-31 $15.19 Million -34.14%
2021-12-31 $23.06 Million -12.82%
2020-12-31 $26.45 Million +3.37%
2019-12-31 $25.59 Million +0.77%
2018-12-31 $25.39 Million +72.85%
2017-12-31 $14.69 Million +319.26%
2016-12-31 $3.50 Million +101.61%
2015-12-31 $1.74 Million --